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Abstract
We investigated the physiological consequences of the most challenging mountain ultra-marathon (MUM) in the world: a
330-km trail run with 24000 m of positive and negative elevation change. Neuromuscular fatigue (NMF) was assessed before
(Pre-), during (Mid-) and after (Post-) the MUM in experienced ultra-marathon runners (n = 15; finish time = 122.43 hours
617.21 hours) and in Pre- and Post- in a control group with a similar level of sleep deprivation (n = 8). Blood markers of
muscle inflammation and damage were analyzed at Pre- and Post-. Mean 6 SD maximal voluntary contraction force
declined significantly at Mid- (213617% and 210616%, P,0.05 for knee extensor, KE, and plantar flexor muscles, PF,
respectively), and further decreased at Post- (224613% and 226619%, P,0.01) with alteration of the central activation
ratio (224624% and 228634% between Pre- and Post-, P,0.05) in runners whereas these parameters did not change in
the control group. Peripheral NMF markers such as 100 Hz doublet (KE: 218618% and PF: 220615%, P,0.01) and peak
twitch (KE: 233612%, P,0.001 and PF: 219614%, P,0.01) were also altered in runners but not in controls. Post-MUM
blood concentrations of creatine kinase (371963045 Ul?1), lactate dehydrogenase (11456511 UI?L21), C-Reactive Protein
(13.167.5 mg?L21) and myoglobin (449.36338.2 mg?L21) were higher (P,0.001) than at Pre- in runners but not in controls.
Our findings revealed less neuromuscular fatigue, muscle damage and inflammation than in shorter MUMs. In conclusion,
paradoxically, such extreme exercise seems to induce a relative muscle preservation process due likely to a protective
anticipatory pacing strategy during the first half of MUM and sleep deprivation in the second half.
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Introduction
Mountain ultra-endurance running has experienced consider-
able growth in recent years. These events consist of running/
walking on mountain trails with positive and negative slopes over a
distance longer than the traditional marathon. These extreme
events are an opportunity to investigate the physiological responses
of the human body when pushed to its limits [1]. Some previous
studies have already assessed the acute consequences of these
mountain ultra-marathons (MUM) on inflammation, neuromus-
cular or cardiac fatigue or hemolysis [2–5] but none of them have
assessed the consequences of an event longer than 50 h. More
precisely, neuromuscular fatigue has been assessed after 5 to 37 h
prolonged running exercises and the general observation was the
presence of large central fatigue [3,4,6] with some slight
differences depending of the muscle group tested, usually knee
extensors (KE) vs. plantar flexors (PF). Moreover, peripheral
fatigue, such as low-frequency fatigue, has also been reported after
a MUM [3]. A plateau in the maximal voluntary contraction
(MVC) force loss (index of global fatigue) has been suggested [7]; it
appears that after approximately 30–36 h of running, MVC force
loss does not increase further. However, to our knowledge, there
are no data available on MUM longer than 37 h to confirm the
presence of this plateau.
Information about inflammation and muscle damage have
already been collected after a MUM [2,3,5] and revealed large
increases of myoglobin, C-reactive protein, lactate dehydrogenase
(LDH) and creatine kinase (CK) concentrations. For example, CK
activities have been reported to be ,13,600 UI?L21 (mean value)
after the Ultra-trail du Mont-Blanc (UTMB). Such levels are
similar to those measured in patients with rhabdomyolysis [8] and
confirm the extreme solicitation of the organism.
Analyzing MUM longer than 100 hours involves sleep depri-
vation, which is not an issue in shorter events. This factor has
never been assessed in previous MUM studies lasting less than 50
h. Little is known about the effects of sleep deprivation on
neuromuscular fatigue and muscle damage. It has been reported
that 24 h of sleep deprivation did not affect weightlifting
performances [9]. Following 30-h sleep deprivation, isokinetic
knee flexion peak torque decreased but no effects were detected on
fatigue index [10]. Electrically evoked force or maximal voluntary
strength did not change during either isometric or isokinetic
contractions of the upper or lower limbs during 60 h of sleep
deprivation [11,12]. These findings suggest that sleep deprivation
per se has little effect on the neuromuscular function.
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Analyzing MUM longer than 100 hours also allows making a
mid-run measurement, which is difficult in shorter duration
MUMs. Effectively, with such a long exercise time, a few minutes
lost for the study won’t have any effect on the final performance.
Finally, the comparison of runners and control subjects has never
been performed on MUM studies.
The aim of the present study was to investigate the etiology of
neuromuscular fatigue, muscle damage and inflammation in the
most extreme (duration: 80–150 h) MUM in the world. By using
data recorded prior to, during and after the event on both runners
and control subjects, we aimed at characterizing the specificities of
such MUM and better describe the underlying mechanisms of
extreme fatigue.
Methods
Experimental design
The race supporting this study was the Tor des Ge´ants (TdG)
2011. It consisted of running/walking ,330 km around the
province of Val d’Aoste in Italy with a total positive and negative
elevation change of ,24000 m (Figure 1). There were 471 starters
and 301 finishers (64%) in 2011. This race is considered as the
world’s most challenging single-stage MUM. The maximum and
minimum altitudes are 3300 m and 322 m, respectively. There are
20 passes over 2000 m. The maximum time allowed for
completion of the race is 150 h and the current record is 76 h.
The distance is divided into seven parts interspersed by six aid-
stations where sleeping is allowed. However, the participants do
not have any compulsory stops and therefore can pace themselves
and manage their stops as they wish. Since the recovery time (e.g.
nutrition, hydration, sleep) is not subtracted from the race time,
the influence of pacing and sleep deprivation is paramount. This
race is therefore different to other mountainous ultra-trails of
shorter distances (e.g. Ultra-trail du Mont-Blanc, UTMB, 166 km
[3]) or road ultra-marathons over longer distance but with several
stages (e.g. Trans Europe Foot Race, 4,487 km in 64 stages from
South Italy to North Cape, Norway in 2009, [13]) where sleep
management is of less importance.
The study was approved by the institutional ethics committee of
the University of Verona, Italy (Department of Neurological,
Neuropsychological, Morphological and Motor Sciences). All
subjects provided written, voluntary, informed consent before
participation. The experiment was conducted according to the
Declaration of Helsinki. Most of the subjects were familiar with
testing procedures, having previously participated in similar
experiments [3,6].
Participants
Twenty-five male runners took part in the present study.
Participants were tested three times: before the run (Courmayeur,
Italy, altitude 1224 m, km 0, Pre-); during the run (Donnas, Italy,
altitude 322 m, km 148.7, Mid-); and approximately 30 minutes
after the run (Courmayeur, Italy, altitude 1224 m, km 330, Post-).
Of the 25 initially engaged participants, 15 (i.e. 60%) completed
the TdG and 9 took part in the three testing sessions (i.e., Pre-,
Mid- and Post-). The finishers/starters ratio for our subjects was
similar to the overall ratio for this race (64%). All subjects were
experienced in ultra-marathons/trails (Table 1). Three subgroups
of runners (Pre-Mid-Post, n = 9; Pre-Mid, n = 15; Pre-Post, n = 15)
were considered in the present study (see statistical analysis for
more details). There was no significant difference between the
three groups (n = 9 and n= 15) for any characteristics (Table 1).
Therefore, the group ‘‘Pre-Mid-Post’’ (n = 9) was considered as
representative and was renamed ‘‘TOR’’.
In parallel, a control group (CON, n= 8) participated in this
study, and was tested at Pre- and Post-. Table 1 shows that TOR
and CON were similar except for age and experience in trail
running. The timing for the Pre- and Post- measurements was
strictly similar in TOR and CON. This control group was
constituted of investigators. Of importance is that both groups
were constrained by the same level of sleep deprivation (Table 1).
Force assessment
MVC force loss of KE and PF was evaluated to provide an
index of global fatigue [14]. The voluntary activation ratio of KE
and PF was assessed using superimposed high-frequency (100 Hz)
doublet to detect central fatigue. Finally, evoked stimulations were
delivered to the relaxed muscle in a potentiated state to determine
the extent and type of peripheral fatigue.
The protocol was identical for the three testing sessions, and was
conducted as follows:
1. One MVC (duration ,4 s).
2. One or two MVCs with a superimposed 100 Hz doublet,
followed by a 100 Hz doublet (,2 s after the MVC), a 10 Hz
doublet and a single twitch (,2–3 s between each stimulation).
A second MVC was performed if a plateau was not observed in
the first one.
This sequence was conducted twice at Pre- and Post- and only
one time at Mid- since the time was limited for the runners during
the race. At Pre-, the first step consisted of determining the
supramaximal stimulation intensity, which was used for all
sessions. In Pre-, subjects performed 8–10 contractions on each
ergometer at intensities ranging from 20–80% of the estimated
MVC as a warm-up. No warm-up was performed for Mid- or
Post-.
For the KE testing, subjects were seated in an isometric
ergometer comprised of a custom-built chair equipped with a
strain gauge (STS 250 kg, sensitivity 2.0005 mV?V21 and 0.0017
V?N21, SWJ, China). Subjects were seated with a knee angle of
90u and a trunk-thigh angle of 100u (180u= neutral position). The
strain gauge was attached to the chair on one end and securely
strapped to the ankle with a custom made mould. Two crossover
shoulder harnesses and a belt limited extraneous movement of the
upper body across the lower abdomen. Subjects were instructed to
cross their arms on the trunk during the MVC. During the MVCs,
subjects were strongly encouraged.
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Figure 1. Altitude profile of the entire run with the three session test locations and the distance scale in km.
doi:10.1371/journal.pone.0065596.g001
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For the PF testing, another specific custom-built ergometer was
used. The forefoot was strapped on this ergometer and the knee
was blocked to limit heel lift during the MVC. Arms were crossed
on the trunk. The hip, knee and ankle angles were set at 90
degrees. Subjects were sitting on a massage table vertically
adjustable. Mechanical torque of the PF muscles was obtained
with an instrumental pedal equipped with a strain gauge sensor
(Vishay Micro Measure, Raleigh, NC) set in bridge of Wheatstone
(set of two perpendicular gauges). The pedal’s body was made of
aluminum (Fortal 7075-T6, Grenoble, France) with an elastic limit
over 500 MPa. The field of the torque measured and tested
extended to 30 kg?m. The lower section of the pedal body was
60 mm wide and 16 mm thick, with a constraint of 120 MPa. To
limit the contribution of muscle groups other than PF and to
optimize force recordings, the upper leg was clamped down to the
pedal just proximal to the knee. Mechanical data were recorded at
1 kHz using an AD conversion system (MP150; Biopac system,
Goleta, CA). The right leg was investigated for all subjects in both
muscle groups. It is important to note, that the right leg was the
dominant one for all subjects. For both KE and PF testing, the
settings of the ergometer were noted to standardize the position of
every subject.
Electrical stimulation
Most of the subjects (75%) had already experienced electrical
stimulation of femoral and tibial nerves [3,6]; thus no familiariza-
tion session was performed. Transcutaneous stimulations were
induced by a high-tension, constant current stimulator (maximal
voltage of 400 V, DS7AH, Digitimer, Hertfordshire, UK). The
doublets were induced by a Train/Delay Generator (Model
DG2A, Digitimer).
For KE, the cathode (5-cm diameter, Dermatrode, American
Imex, Irvine, CA) and the anode (5610 cm, Medicompex SA,
Ecublens, Switzerland) were placed over the femoral nerve at the
femoral triangle level beneath the inguinal ligament and on the
lower part of the gluteal fold opposite to the cathode, respectively.
For the PF, the anode (1065 cm, rectangular self-adhesive
stimulation electrode, Medicompex SA) was located on the
inferior base of the quadriceps muscle and the cathode (EMG
electrode, 10 mm diameter, Kendall Meditrace 100, Tyco,
Canada) was located on the tibial nerve in the popliteal cavity.
The maximal stimulation intensity was measured during the
first testing session by progressively increasing the intensity until a
plateau was observed for the mechanical (peak twitch) and
electrical (M-wave amplitude) responses. This stimulation intensity
was then increased by 50% to obtain supramaximal intensity.
Electromyographic recordings
The EMG signals of the right vastus lateralis (VL) and soleus (SOL)
were recorded using bipolar silver chloride surface electrodes of
10-mm diameter (Kendall Meditrace 100) during the MVC and
electrical stimulation. These muscles were chosen as VL has been
proposed as a surrogate for the quadriceps muscle [15] and SOL is
the main muscle contributing to plantar flexor force at a knee
angle of 90u [16]. The recording electrodes were taped on the skin
over the muscle belly following SENIAM recommendations [17],
with an inter electrode distance of 20 mm [18]. The position of the
electrodes was marked on the skin so that they could be fixed on
the same place for the two other sessions. The reference electrode
was attached on the patella (for both VL and SOL EMG). Low
impedance (,10 kV) at the skin-electrode contact was obtained by
shaving,abrading the skin with an abrasive sponge and cleaning
with alcohol. EMG data were recorded with Biopac system
(MP150, Biopac System, Goleta, CA) and amplified (gain = 1000)
with a bandwidth frequency ranging from 10 to 500 Hz, digitized
at a sampling frequency of 2 kHz, and recorded by the AD
conversion system (common mode rejection ratio: 90 dB, input
impedance: 100 MV; gain: 1000). Isometric force and EMG data
were stored and analyzed offline with commercially available
software (Acqknowledge 4.1 software, Biopac System, Goleta,
CA).
Blood samples
Peripheral venous blood was collected at Pre- and Post- by
peripheral venipuncture into siliconized vacuum tubes containing
either K2 EDTA (Becton-Dickinson, Oxford, UK) for blood count
analysis (Advia 2120, Siemens, Germany) or lithium heparin for
clinical chemistry testing (Modular Analytics, Roche, Switzerland).
The samples were stored in a refrigerated bag and transported to
the reference laboratory for analysis. The quality of the results was
validated by regular internal quality control procedures and
participation in an External Quality Assessment Scheme. For
further details, see [19,20].
General fatigue and peripheral pain. Subjects were
requested to quantify the levels of general fatigue and subjective
pain (e.g. muscle soreness, joint pain) in three anatomical areas
(foot-ankle; leg-knee; thigh-hip) and their digestive feelings by
using a visual analog scale (VAS) with a 100-mm horizontal line
with ‘‘no fatigue/no pain’’ on one end (0 mm) and ‘‘extremely
fatigued/painful’’ on the other (100 mm). Subjects were asked to
mark their pain level on the VAS under supervision of an
examiner.
Table 1. Main characteristics of the different groups.
Group N Age (yr) Height (cm) Mass (kg) Body fat (%)
Training
(h?wk21)
Year of expe
rience in trail
running (yr)
Sleep at
Mid (h)
Sleep at
Post (h)
Total runners 25 45.4610.3 17465 69.466.1 18.462.9 8.265.1 7.765.3 - -
‘‘Pre-Mid-Post’’
(TOR)
9 41.6613.1 17466 67.366.4 17.863.3 7.264.1 7.866.9 1.261.6 8.665.2
‘‘Pre-Mid’’ 15 45.1611.9 17466 71.066.2 17.563.3 7.164.4 8.165.5 1.962.1 9.965.4
‘‘Pre-Post’’ 15 44.7611.3 17465 67.965.8 18.463.2 7.865.2 7.465.5 1.461.8 9.164.8
Control (CON) 8 29.368.1# 17466 70.969.3 20.166.1 2.762.5 0.861.2 1.261.8 12.365.4
Data are mean6 SD. Training volume was considered for the past trail running season. Mid-: during the run at Donnas, km 148.7. Post-: about 30 minutes after the race,
at Courmayeur. Sleep represents the sleeping time accumulated at Mid- and Post-. #: P,0.001 for differences between control and other groups.
doi:10.1371/journal.pone.0065596.t001
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Mechanical responses
Peak force measured during the highest MVC for each session
was considered as the MVC value. The amplitudes of the
potentiated low- (10 Hz, PS10) and high-frequency (100 Hz,
PS100) doublets, potentiated twitch (Pt) and superimposed high-
frequency doublet and the ratio of high- to low-frequency doublet
peak force (PS10/100) were analyzed for the KE and the PF. For
these parameters, the values obtained during or after the highest
MVC were considered for each muscle group. The PS10/100
ratio was used to assess the development of low frequency fatigue
(LFF) [21].
MVC force and central activation
The Central Activation Ratio (CAR) was was calculated as
follows [22]:
Central Activation Ratio~
MVC force= MVC forcez superimposed doublet amplitudeð Þ
EMG
The M-wave peak-to-peak duration and amplitude were
measured from VL and SOL muscles. They were analyzed from
the single potentiated twitch evoked on the relaxed muscle. The
EMG Root Mean Square (RMS) values for VL and SOL muscles
at peak torque level were calculated during the highest MVC trial
over a 500 ms period (250 ms period either side of the peak
torque).
Statisticical analysis
Data were screened for normality of distribution and homoge-
neity of variance using a Shapiro-Wilk normality test and the
Barlett’s test, respectively.
First, we tested differences across the testing sessions for the
three different experimental groups (TOR, n= 9; Pre-Mid, n= 15;
Pre-Post, n = 15). When conditions of analysis of variance
(ANOVA) application were met, each variable was compared
between the different times of measurements (Pre-Mid-Post, n = 9;
Pre-Mid, n= 15; Pre-Post, n = 15) using a repeated measures
ANOVA for the experimental sub-groups. Bonferroni corrections
were applied to determine between-means differences if the
ANOVA revealed a significant main effect. When conditions of
application for parametric repeated-measures ANOVA were not
met, Friedman ANOVA was used.
Second, we examined the TOR vs CON differences: a repeated
measures ANOVA was used to identify differences by examination
of the group (TOR vs CON) x time (Pre- vs. Post-) interaction,
complemented by a Bonferroni post-hoc test. When the conditions
of application were not met, a Mann-Whitney rank-sum test was
used.
Third, for comparison of the percent decreases in neuromus-
cular parameters between TdG and a previous study with the
same experimental method (i.e. UTMB [3]), unpaired t-tests were
used.
Pearson correlation coefficients were calculated between Pre- to
Post-MUM changes in neuromuscular and blood parameters.
For all statistical analyses, a P value of 0.05 was accepted as the
level of significance. All data presented as mean values 6 SD in
the text and tables and as mean values 6 SE in figures.
Results
Considerations about groups and subgroups
There was no significant difference between groups (TOR, Pre-
Post and Pre-Mid) in terms of age, height, weight and running
time. Furthermore, for all subsequent analyses and discussion, only
the TOR group has been used. However, we did report the
changes for the other two sub-groups in the figures to show that
the TOR group was representative of the other groups, as done in
a previous study. [3]
Performance and muscle fatigue
The average finishing time of our subjects was 122.43 hours
617.21 hours, their final rank being from 8th to 244th position out
of 301 finishers.
MVC declined significantly (Figure 2) at Mid- (212.6617.4%
and 29.7616.4% for KE and PF, respectively; P,0.05), and
further decreased at Post- (223.9613.1%; P,0.01 and
226.4619.1%, respectively; P,0.001). For the control group,
MVC was not significantly reduced between Pre- and Post- both
for KE (216.5615.1%) and PF (21.6612.9%).
Central fatigue
CAR decreased significantly for both KE and PF
(222.1616.2% and 229.2624.5% for KE and PF respectively)
muscles in TOR but no change was observed in CON (Table 2).
Peripheral fatigue
PS100 was significantly reduced for both muscle groups in TOR
(217.9617.8% and 219.9615.2% for KE and PF, respectively;
P,0.01). No significant decrease was observed in CON (Figure 3).
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Figure 2. Maximal voluntary contraction (MVC) prior to (Pre-),
in the middle of (Mid-) and after (Post-) the race for knee
extensors (KE, panel A) and plantar flexors (PF, panel B). A two-
way repeated measure ANOVA was used complemented by a
Bonferroni post-hoc test. Values are mean 6 SE.
doi:10.1371/journal.pone.0065596.g002
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Peak twitch was significantly reduced for both KE and PF muscles
in TOR (233.6612.3%, P,0.001 and 219.3613.6%, P,0.01
for KE and PF, respectively), but no change was observed in CON
(Figure 4). The PS10/100 ratio decreased significantly at Mid- for
PF (26.168.3%, P,0.01) but no change was reported for KE.
The other peripheral fatigue markers are presented in Table 3.
Blood analysis
We found significant increases in the main inflammation and
muscle damage markers in TOR. These results are presented in
Table 4. Changes in Na+, K+, Ca2+, glucose, myoglobin and total
protein are given in Tables 4 and 5. No significant correlation
between the Pre- to Post- changes in neuromuscular parameters
and changes in blood variables was found.
Comparison with the UTMB study
We compared our main results to previous data collected in a
previous study during UTMB, [3] (Figure 5). The anthropome-
trical values of the subjects were similar between TdG and
UTMB. There was no significant difference between TdG at Mid-
and UTMB in distance, elevation, running time or relative rank
(Table 6). To compare the difference in speeds, we used a flat-
equivalent speed calculated as:
flat-equivalent distance~
distance kmð Þz positive elevation change mð Þ=100:
General fatigue and peripheral pain
The changes in general fatigue, pain in foot-ankle and knee-
thigh-hip and digestive feelings are displayed in Figure 6. The
increase in these four variables was significant in TOR from Mid-
whereas no changes were observed in CON.
No significant correlation was found between the changes in
general fatigue or peripheral pain (measured with VAS) and the
changes in neuromuscular parameters.
Table 2. Central activation ratio (CAR, %) for the knee
extensors (KE) and the plantar flexors (PF) prior to (Pre-), in the
middle of (Mid-) and after (Post-) the race in runners (TOR,
n = 9) and control group (CON, n = 8).
CAR
(%) KE PF
Pre Mid Post Pre Mid Post
TOR 91.265.9 87.568.7 71.1626.5* 89.0610.3 87.3613.7 63.0638.7*
CON 88.566.8 - 82.3610.1 85.7617.2 - 83.8615.1
Values are given as mean 6 SD. *: P,0.05 for differences in TOR between Pre-
and Post-.
doi:10.1371/journal.pone.0065596.t002
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Figure 3. Amplitude of the potentiated doublet (PS100) prior
to (Pre-), in the middle of (Mid-) and after (Post-) the race for
knee extensors (KE, panel A) and plantar flexors (PF, panel B).
A two-way repeated measure ANOVA was used complemented by a
Bonferroni post-hoc test. Values are mean 6 SE.
doi:10.1371/journal.pone.0065596.g003
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Figure 4. Amplitude of the potentiated peak twitch (Pt) prior to
(Pre-), in the middle of (Mid-) and after (Post-) the race for knee
extensors (KE, panel A) and plantar flexors (PF, panel B). A two-
way repeated measure ANOVA was used complemented by a
Bonferroni post-hoc test. Values are mean 6 SE.
doi:10.1371/journal.pone.0065596.g004
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Discussion
The purpose of the present study was to investigate neuromus-
cular and biological adjustments occurring during and after a
single-stage MUM lasting between 4 and 7 days and inducing a
large magnitude of sleep deprivation. The main results of the
present study are that, compared to similar events of one-quarter
to half the distance: (i) the neuromuscular function was generally
less altered and (ii) muscle damage and inflammation markers (e.g.
CK, LDH, C-RP) were much lower. This suggests that the pacing
strategy (i.e. slow pace from the beginning of the race) and sleep
deprivation that result in very low-intensity concentric/eccentric
contractions preserve the neuromuscular function despite the
apparent extreme difficulty of this event.
Neuromuscular fatigue induced by the TdG
Central and peripheral alterations. At Post-MUM, MVC
was significantly decreased in TOR but not in CON. When
comparing the TdG with the UTMB [3] the decreases were lower
for KE and tended to be lower for the PF (224% vs. 232% in
KE; 226% vs. 238% in PF, for TdG vs. UTMB, respectively).
Surprisingly, over a MUM of longer distance and duration and
greater elevation change, the magnitude of MVC force loss was
lower than in shorter MUMs. These findings complement
previous results presenting a MVC force loss – exercise duration
Table 3. Values of potentiated peak twitch (N for knee extensors and Newton.meter: N?m for plantar flexors) and M-wave peak-to-
peak amplitude (millivolts: mV) and peak-to-peak duration (ms) for the knee extensors (KE) and the plantar flexors (PF) prior to (Pre-
), in the middle of (Mid-) and after (Post-) the race in runners (TOR, n = 9) and control group (CON, n = 8).
KE PF
TOR CON TOR CON
Pre Mid Post Pre Mid Post Pre Mid Post Pre Mid Post
Potentiated Peak
Twitch
(N or N?m)
95.1622.2 89.5623.4 67.9621.3* 95.7629.7 - 95.2611.3# 31.166.5 28.869.4 24.965.5 28.966.8 - 26.369.4
M-wave
Peak-to-peak
Amplitude (mV)
15.1 68.8 14.165.9 12.5 65.8 17.567.3 - 14.967.8 9.562.7 9.664.3 12.866.6 11.662.1 - 9.963.6
M-wave
Peak-to-peak
duration (ms)
8.8 61.9 8.7 62.1 8.6 62.3 7.862.3 - 7.8 62.5 2.860.5 3.461.5 3.361.2 2.960.4 - 2.860.8
Values are given as mean 6SD. N = 8 and n = 9 for CON and TOR respectively. *: P,0.05 for differences with Pre; #: P,0.05 for differences between TOR and CON.
doi:10.1371/journal.pone.0065596.t003
Table 4. Main blood markers of muscle damage and
inflammation prior to (Pre-) and after (Post-) the race in
runners (TOR, n = 9) and control group (CON, n = 6).
Pre Post
Creatine Kinase (UI ? L21)
TOR 112633 371963045***
CON 122.5641.1 147.7632.6###
Lactate Dehydrogenase (UI ?
L21)
TOR 340651 11456511***
CON 345665 312635###
C-Reactive Protein (mg ? L21)
TOR 0.3160.32 13.1167.51***
CON 1.0561.04 0.6560.61##
Creatinine (mmol ? L21)
TOR 0.9460.12 0.9560.15
CON 0.9860.18 1.0160.17
Myoglobin (mg ? L21)
TOR 25.665.5 449.36338.2***
CON 26.168.4 32.3616.4###
Total Protein (g ? L21)
TOR 72.763.9 64.964.6***
CON 72.462.9 73.163.4
Data are mean values 6 SD. ***: P,0.001 for differences between Pre- and
Post-. ##: P,0.01, ###: P,0.001 for differences between groups.
doi:10.1371/journal.pone.0065596.t004
Table 5. Changes in Na+ K+, Ca2+ and glucose concentration
prior to (Pre-) and after (Post-) the race in runners (TOR, n = 9)
and control group (CON, n = 6).
Pre Post
Na+ (mmol ? L21)
TOR 141.161.9 138.363.4
CON 140.760.8 140.260.4
K+(mmol ? L21)
TOR 5.160.9 7.162.1*
CON 5.560.2 4.760.4##
Ca2+(mmol ? L21)
TOR 9.660.3 8.362.3***
CON 9.860.2 9.960.2###
Glucose (mmol ? L21)
TOR 4.860.7 4.360.8
CON 4.360.5 4.960.5**#
Values are given as mean 6 SD. *: P,0.05, **: P,0.01, ***: P,0.001 for
differences between Pre- and Post-. #: P,0.05, ##: P,0.01, ###: P,0.001
for differences between groups.
doi:10.1371/journal.pone.0065596.t005
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relationship [6,23]. In these previous studies, the authors described
an increase in KE MVC force loss as running duration increases
and then ‘‘a plateau for extreme durations.’’ This relationship was
observed for durations between 2 and 37 h (i.e. less than 2 days).
The present results highlight that for durations between 4 and
7 days, the loss in maximal force generating capacity may be even
lower than the above-described ‘‘plateau.’’ This can be explained
by the large deceleration throughout the MUM (Table 6) and
consequently the relative low intensity during the second part of
the race due to the accumulation of kilometers, elevation and sleep
deprivation. Compared to shorter races, both the speed, especially
at the end, and strength loss were lower.
It is interesting to compare the present results with a preceding
study conducted on during the UTMB [3]. For a similar distance,
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Figure 5. Decrease in MVC force for UTMB (Ultra-Trail du Mont-Blanc), the TdG (Tor des Geants) and TdG at mid-race (Mid) for the
knee extensors (KE, panel A) and the plantar flexors (PF, panel B) and decrease in peak twitch for the UTMB, the TdG and TdG Mid
for the knee extensors (panel C) and the plantar flexors (panel D). Unpaired t-tests were used. Data are given in changes from Pre- values.
doi:10.1371/journal.pone.0065596.g005
Table 6. Comparison of parameters concerning the different run (TdG: Tor des Geants; UTMB: Ultra Trail du Mont-Blanc) properties
and subjects.
Parameters TdG TdG Pre-Mid TdG Mid-Post UTMB
Equivalent flat distance (km) 545 241 304 262
Average equivalent-flat speed (km/h) 5.562.8 6.262.1* 4.560.4*$ 7.261.3*${
Speed decrease relative to UTMB (%) 223.1 214.1* 236.8*$ -
D+ (m) 24000 11500 12500 9600
Relative rank (% field) 34 - - 38
Time (h) 107.5615.4 39.165.9* 67.163.3*$ 37.665.9*{
Age (Yr) 45.4610.3 45.4610.3 45.4610.3 40.267.4
Height (cm) 17365 17365 17365 17867
Weight (kg) 69.466.1 69.466.1 69.466.1 73.466.4
Values are given in mean 6 SD. Equivalent-flat distance was calculated as follows: (positive elevation (m)/100) + distance (km). *: P,0.05 different from TdG; $: P,0.05
different from TdG Pre-Mid; {: P,0.05 different from TdG Mid-Post.
doi:10.1371/journal.pone.0065596.t006
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running time and elevation, the decrease in MVC was two times
greater in UTMB than Mid-TdG in KE (231% vs. 213% for
UTMB and Mid-TdG, respectively) and four times greater in PF
(240% vs. 210%). When compared to UTMB, the ,15% lower
running speed induced one-quarter to half the MVC force loss.
These differences may be explained by the pacing strategy [24]. In
the pacing strategy model, the athlete generates a conscious RPE
managed by his brain, which assimilates all afferent information
from each physiological system. The work output is then adjusted
so that RPE does not increase disproportionately during the
exercise, to avoid premature exercise termination. This pacing
strategy is adopted by the runners in order to preserve themselves
for the rest of the run; this can explain the lower decrease in MVC
force observed Mid-TdG compared to UTMB.
The central component of fatigue after ultra-endurance exercise
has been proposed as the main explanation for neuromuscular
fatigue in KE [3,4,6], and it has been shown that this central drive
alteration was not as high for PF as for KE after a 24–h treadmill
run [25]. The present study partially confirmed these observations
since the decrease in %CAR was significant in both muscle
groups. These results could confirm the existence of a central
mechanism already described in the UTMB [3] and whose
purpose is ‘‘to reduce neural input to working muscles to limit
fatigue and damage’’[7,26]. As expected, peripheral fatigue was
also observed in this study, highlighted by the decreases in PS100
and peak twitch amplitude. Our results also suggest that muscle
excitability was well-preserved [27] since no significant alteration
was found in the M-wave properties. This confirms previous
results obtained after various endurance exercises [23,28].
Therefore, it rather seems that processes located beyond action
potential propagation/transmission were impaired. The reduction
in electrically evoked force can thus be attributed to the
impairment of some steps of the excitation-contraction coupling
mechanism and could involve (i) a reduced number of active cross-
bridges due to a decreased release of Ca2+; (ii) a decreased
sensitivity of the myofilaments to Ca2+; and/or (iii) a reduced force
produced by each active cross-bridge [29]. Recent data seem to
favor decreased Ca2+ release from the sarcoplasmic reticulum as
an important contributor to fatigue after prolonged exercise and
was explained by leaky ryanodine receptors, the Ca2+ release
channels in the muscle [30]. This hypothesis is in accordance with
the decrease in PS10/100 in the PF at Mid-, which revealed the
presence of low-frequency fatigue (LFF) in this muscle as observed
in the UTMB. In addition, it is interesting to note that for the
same distance, time and elevation, the decrease in Pt was minimal
(e.g. 5% and 8% at Mid- for the KE and PF respectively) and 3–4
fold greater in the UTMB (19% and 26%, respectively). This is in
line with MVC loss described above and illustrates the conserva-
tive pacing strategy [7,24,31].
The reduction in speed, the sleep deprivation and the
underlying respective feedback vs. feed-forward components of
the pacing regulation are among the putative factors explaining
this reduced strength loss observed in TdG, when compared to
shorter distances. During the second part of the TdG (Mid-to-
Post), the average flat-equivalent speed was 4.5 km?h21 and was
37% lower than in UTMB (Table 6). Most of the participants were
only walking during the final part of the TdG. Even the best
athletes had a larger proportion of walking vs. running than in
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Figure 6. Visual analogue scale (VAS) for the pain-foot-ankle (panel A), the knee-thigh-hip (panel B), the digestive feeling (panel C)
and the general fatigue (panel D) for runners (TOR) and control group (CON) prior to (Pre-), in the middle of (Mid-) and after (Post-)
the race. A two-way repeated measure ANOVA was used complemented by a Bonferroni post-hoc test. Values are mean 6 SE.
doi:10.1371/journal.pone.0065596.g006
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UTMB and thus less mechanical stress on the muscles [32]. This
involved smaller forces on lower limb muscles resulting in a less
eccentric work since downhill running leads to important eccentric
contractions, especially for the KE [33,34] knowing that muscle
damage is greater with fast- than slow- velocity eccentric exercise
[35]. In addition, the energetic cost of downhill walking is lower
than for downhill running [36] and one cannot exclude that this
might contribute to the pacing of the subjects. However, the
influence of economy on MUM performance is unclear and is still
being debated [37,38].
We already mentioned that the reductions in MVC force and
peak twitch, when compared to the UTMB, were likely due to a
specific pacing strategy [24]. This is supported by the VAS
‘‘fatigue’’ and ‘‘pain’’ values that were all significantly lower at
Mid- than at Post- (except ‘‘igestive feelings’’). Of interest is that
‘‘general fatigue’’ at Mid- was not different between TOR and
CON (Figure 6); however we cannot distinguish the influence of
nociceptive feedback on this decrease in strength.
An important point in this study, which differentiates it from
previous studies on ultra-endurance, is the severe sleep deprivation
(Table 1). Although this possibility that sleep deprivation
negatively affects voluntary strength has previously been proposed
[10], it is difficult to attribute the loss of voluntary strength in
TOR to the sleep deprivation since no significant strength loss was
observed in CON constrained to the same amount of deprivation.
The results of CON are in agreement with the rare studies
examining the effects of sleep deprivation itself on neuromuscular
function. On the contrary, several studies have illustrated an
injurious effect of sleep deprivation on endurance performance
[7,39,40]. Moreover, sleep deprivation one of the centrally acting
performance factors presented in different models of performance
regulation [7,31] and can therefore influence pacing strategies.
Indeed, a lack of sleep is known to have an influence on the RPE
for a given exercise [39,41]; i.e. the perceived exertion is higher
with partial or total sleep deprivation. Thus, this factor can
influence the pacing strategy by decreasing the speed in order to
maintain a sufficient security reserve as described by Millet [7].
Biological markers of fatigue
As expected, a 330-km/24000 m D+ (i.e. total positive elevation
change) ultra-marathon led to a large increase in main blood
markers of muscle damage and inflammation. As already observed
in UTMB [3], there was a large variability among subjects for the
biological parameters.
CK increased to a large extent in TOR whereas there was no
change in CON. However, the post-race level of CK in TOR was
much lower than after UTMB (3700 vs. 13600 UI.L21 for TdG
and UTMB, respectively). These results are also much lower than
the values measured after the Western States Endurance Run (161
km and 5500 m D+/7000D-,[2]). It is well known that downhill
running involves a large eccentric component, especially for the
KE [33,34] and leads to large increases in muscle damage
markers, principally CK [42,43]. Our relatively low CK values
despite the extremely high downhill component of the TdG
highlight the influence of running speed on the magnitude of
muscle damage [43]. This relative muscle preservation is also
illustrated by the increase in myoglobin concentration being much
lower than after UTMB [5]. As discussed above, the final part of
the TdG was walked by most of the participants mainly due to
nociceptive feedback and sleep deprivation-induced fatigue. This is
in line with CK values of ‘only’ 4500 UI.L21 after a 1600-km
‘‘flat’’ ultra-marathon [44].
An interesting inflammation marker measured in our study was
C-RP. This increased in TOR, showing a great inflammation
process but this rise remained lower than the one observed in
UTMB (46.8 vs. 13.1 mg?L21 for UTMB and TdG, respectively),
indicating less inflammation in TdG and in line with the lower
muscle damage described above. Of interest is also that the
increase in LDH concentration (+240%) was similar compared to
the UTMB (+274%) [3,5]. The decrease in total protein suggests
an increase in plasma volume and these results are also in line
with the UTMB data [5] and with other previous endurance
exercises [45,46]. This may confirm the inflammation process
which had probably occurred in our case. Other mechanical
parameters must be considered. The level of tension is recognized
as a primary factor for exercise-induced muscle damage [47].
Since participants run faster in UTMB than on TdG, they
consequently produced greater muscle forces during propulsive
(concentric) actions. Stronger eccentric contractions were thus
needed to absorb the potential energy during ground contact
phase. More importantly, wider amplitudes are thus needed to
perform these braking phases, especially for the knee and ankle
joints [48]. The higher levels of tension associated with large
movement amplitudes induce greater mechanical stress (length-
ening) on muscle fibers [49,50] and importantly affect the level of
exercise-induced muscle damage [51]. These considerations
could explain the present finding and are in line with the pacing
strategy adopted and described above.
The purpose of this study was to assess the physiological impact
of the world’s most challenging mountainous ultra-marathon
(TdG, 330 km; 24000 m D+). This competition is unique since it
represents the greatest elevation change and distance ever
performed over a single-stage mountainous ultra-marathon,
inducing an amazing level of sleep deprivation. To our
knowledge, the experimental design (inclusion of measurements
at mid-race and comparison with a control group constrained to
the same amount of sleep deprivation) is also unique and the first
one allowing investigation of the pacing strategy and the
responses to extreme fatigue induced by distance, elevation and
sleep deprivation. We believe that ultra-endurance is an
interesting model to better understand the pacing/coping
strategies and adaptive responses of athletes facing extreme load
and stress [1].
Over the TdG, an anticipatory pacing strategy was observed
during the first part of the race. Then fatigue combined with a
high level of sleep deprivation led to a large decrease in speed,
particularly during the second part of the race, so that speed was
relatively low over the whole course. This event induced lower
inflammatory responses and less muscle damages than similar
types of events of shorter duration, probably as a result of the very
low concentric/eccentric contraction intensity due to the slow
pace, showing that the amount of neuromuscular fatigue is not
necessarily correlated to the difficulty of the event (duration and/
or elevation). In addition, a control group allowed us to minimize
the effects of sleep deprivation as the main factor of the
neuromuscular fatigue in the runners.
In conclusion, beyond the influence of exercise duration on
ultra-distance trails, the reduction in maximal force generating
capacity seems to be related to other unidentified factors.
Paradoxically, such an extreme MUM seems to induce relative
muscle preservation. Further studies focusing on injuries and pain
are required to complete the understanding of the physiological
impact of such non-standard exertions.
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